Activation of pulmonary mitogen-activated protein kinases during cardiopulmonary bypass

Journal of Surgical Research

Volumn 115, Issue 1, 2003, Pages 56-62

  Khan, Tanveer A ^a   Bianchi, Cesario ^a   Araujo, Eugenio G ^a   Ruel, Marc ^a   Voisine, Pierre ^a   Sellke, Frank W ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cardiopulmonary bypass; ERK1 2; Inflammation; MAPK; p38; Pulmonary

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHUS MUSCLE; CARDIOPULMONARY ARREST; CARDIOPULMONARY BYPASS; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEPARINIZATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERMETHOD COMPARISON; LEUKOCYTE; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; STERNOTOMY; SWINE; TISSUE DISTRIBUTION; TISSUE WATER; WESTERN BLOTTING;

EID: 0142186821     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00236-1     Document Type: Article

References (20)

1. Taggart D.P., el-Fiky M., Carter R., Bowman A., Wheatley D.J. Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann. Thorac. Surg. 56:1993;1123.
2. Asimakopoulos G., Smith P.L., Ratnatunga C.P., Taylor K.M. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann. Thorac. Surg. 68:1999;1107.
3. Edmunds L.H. Jr. Inflammatory response to cardiopulmonary bypass. Ann. Thorac. Surg. 66:(5 Suppl):1998;S12. discussion S25.
4. Araujo E.G., Bianchi C., Sato K., Faro R., Li X.A., Sellke F.W. Inactivation of the MEK/ERK pathway in the myocardium during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 121:2001;773.
5. Araujo E.G., Bianchi C., Faro R., Sellke F.W. Oscillation in the activities of MEK/ERK1/2 during cardiopulmonary bypass in pigs. Surgery. 130:2001;182.
6. Hashimoto N., Takeyoshi I., Yoshinari D., Tsutsumi H., Tokumine M., Totsuka O., Sunose Y., Ohwada S., Matsumoto K., Morishita Y. Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to Euro-Collins solution on reperfusion injury in canine lung transplantation1. Transplantation. 74:2002;320.
7. Karamsetty M.R., Klinger J.R., Hill N.S. Evidence for the role of p38 MAP kinase in hypoxia-induced pulmonary vasoconstriction. Am. J. Physiol. Lung Cell Mol. Physiol. 283:2002;L859.
8. Thorpe G.H., Kricka L.J. Enhanced chemiluminescent reactions catalyzed by horseradish peroxidase. Methods Enzymol. 133:1986;331.
9. Correa-Meyer E., Pesce L., Guerrero C., Sznajder J.I. Cyclic stretch activates ERK1/2 via G proteins and EGFR in alveolar epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 282:2002;L883.
10. Uhlig U., Haitsma J.J., Goldmann T., Poelma D.L., Lachmann B., Uhlig S. Ventilation-induced activation of the mitogen-activated protein kinase pathway. Eur. Respir. J. 20:2002;946.
11. Royston D., Minty B.D., Higenbottam T.W., Wallwork J., Jones G.J. The effect of surgery with cardiopulmonary bypass on alveolar-capillary barrier function in human beings. Ann. Thorac. Surg. 40:1985;139.
12. Ragette R., Fu C., Bhattacharya J. Barrier effects of hyperosmolar signaling in microvascular endothelium of rat lung. J. Clin. Invest. 100:1997;685.
13. Verin A.D., Liu F., Bogatcheva N., Borbiev T., Hershenson M.B., Wang P., Garcia J.G. Role of ras-dependent ERK activation in phorbol ester-induced endothelial cell barrier dysfunction. Am. J. Physiol. Lung Cell Mol. Physiol. 279:2000;L360.
14. Goldberg P.L., MacNaughton D.E., Clements R.T., Minnear F.L., Vincent P.A. p38 MAPK activation by TGF-beta1 increases MLC phosphorylation and endothelial monolayer permeability. Am. J. Physiol. Lung Cell Mol. Physiol. 282:2002;L146.
15. Tonz M., Mihaljevic T., von Segesser L.K., Fehr J., Schmid E.R., Turina M.I. Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible. Chest. 108:1995;1551.
16. Tamura D.Y., Moore E.E., Johnson J.L., Zallen G., Aiboshi J., Silliman C.C. p38 mitogen-activated protein kinase inhibition attenuates intercellular adhesion molecule-1 up-regulation on human pulmonary microvascular endothelial cells. Surgery. 124:1998;403. discussion 408.
17. Friedman M., Wang S.Y., Sellke F.W., Cohn W.E., Weintraub R.M., Johnson R.G. Neutrophil adhesion blockade with NPC 15669 decreases pulmonary injury after total cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 111:1996;460.
18. Nick J.A., Young S.K., Brown K.K., Avdi N.J., Arndt P.G., Suratt B.T., Janes M.S., Henson P.M., Worthen G.S. Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J. Immunol. 164:2000;2151.
19. Hashimoto S., Gon Y., Matsumoto K., Takeshita I., Horie T. N-acetylcysteine attenuates TNF-alpha-induced p38 MAP kinase activation and p38 MAP kinase-mediated IL-8 production by human pulmonary vascular endothelial cells. Br. J. Pharmacol. 132:2001;270.
20. Amrani Y., Ammit A.J., Panettieri R.A. Jr. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells Role of p38 and p42/44 mitogen-activated protein kinases. Mol. Pharmacol. 60:2001;646.